At 59.9x trailing earnings but only 12.9x forward earnings, the market is clearly pricing in a sharp earnings inflection, and that compression alone makes AFRM statistically compelling if execution holds. A 4.6x Price/Sales and 4.6x Price/Book multiple are not stretched relative to a 24.20% ROE and 8.00% operating margin, suggesting the business is producing real economic returns rather than purely narrative-driven growth. However, the 2.2 Altman Z-Score sits in the gray zone, meaning balance sheet safety is adequate but not fortress-level, and investors are implicitly betting that forward earnings of $0.85 justify the rerating. This is a classic GARP setup: multiple contraction plus operating leverage — but only if credit quality and funding conditions remain stable.